At-home testing sales will expand through 2035, with digital monitoring systems at 48.2% of the product type category and blood glucose testing at 56.2% of application demand in 2025. The market was valued at USD 7,789.1 million in 2025 and is forecast to record a 4.8% CAGR between 2025 and 2035.